135
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

Characterization of β-Lactotensin, a Bioactive Peptide Derived from Bovine β-Lactoglobulin, as a Neurotensin Agonist

, , , , &
Pages 940-943 | Received 17 Jan 2003, Accepted 05 Feb 2003, Published online: 22 May 2014

  • 1) Yoshikawa, M., Sasaki, R., Chiba, H., and Tani, F., Japan Kokai Tokkyo Koho, 220197 (Sep. 27, 1991).
  • 2) Gully, D., Canton, M., Boigegrain, R., Jeanjean, F., Molimard, J. C., Poncelet, M., Gueudet, C., Heaulme, M., Leyris, R., Brouard, A., Pelaprat, D., Labbe-Julle, C., Mazella, J., Soubrie, P., Maffrand, J. P., Rostene, W., Kitabgi, P., and Le Fur, G., Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. USA, 90, 65-69 (1993).
  • 3) Carraway, R., and Leeman, S. E., The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem., 248, 6854-6861 (1973).
  • 4) Tyler-McMahon, B. M., Boules, M., and Richelson, E., Neurotensin: peptide for the next millennium. Regulatory Peptides, 93, 125-136 (2000).
  • 5) Labbe-Julle, C., Deschaintres, S., Gully, D., Le Fur, G., and Kitabgi, P., Effect of the nonpeptide neurotensin antagonist, SR48692, and two enantiomeric analogs, SR48527 and SR49711, on neurotensin binding and contractile responses in guinea pig ileum and colon. J. Pharmacol. Exp. Ther., 271, 267-276 (1994).
  • 6) Gully, D., Lespy, L., Canton, M., Rostene, W., Kitabgi, P., Le Fur, G., and Maffrand, J. P., Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin. Life Sciences, 58, 665-674 (1996).
  • 7) Remaury, A., Vita, N., Gendreau, S., Jung, M., Arnone, M., Poncelet, M., Culouscou, J. M., Le Fur, G., Soubrie, P., Caput, D., Shire, D., Kopf, M., and Ferrara, P., Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not analgesia. Brain Res., 953, 63-72 (2002).
  • 8) Dubuc, I., Sarret, P., Labbe-Julle, C., Botto, J. M., Honore, E., Bourdel, E., Martinez, J., Costentin, J., Vincent, J.P., Kitabgi, P., and Mazella, J., Identification of the receptor subtype involved in the analgesic effect of neurotensin. J. Neurosci., 19, 503-510 (1999).
  • 9) Tyler, B. M., Groshan, K., Cusack, B., and Richelson, E., In vivo studies with low doses of levocabastine and diphenhydramine, but not pyrilamine, antagonize neurotensin-mediated antinociception. Brain Res., 787, 78-84 (1998).
  • 10) Vita, N., Oury-Donat, F., Chalon, P., Guillemot, M., Kaghad, M., Bachy, A., Thurneyssen, O., Garcia, S., Poinot-Chazel, C., Casellas, P., Keane, P., Le Fur, G., Maffrand, J.P., Soubrie, P., Caput, D., and Ferrara, P., Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Eur. J. Pharmacol., 360, 265-272 (1998).
  • 11) Mullally, M. M., Meisel, H., and FitzGerald, R. J., Synthetic peptides corresponding to α-lactoalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. Hoppe-Seyler, 377, 259-260 (1996).
  • 12) Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L., and Inagami, T., Effect on blood pressure and exploratory behavior of mice lacking the angiotensin II type 2 receptor. Nature, 377, 748-750 (1995).
  • 13) Yamauchi, R., Sonoda, S., Jinsmaa, Y., and Yoshikawa, M., Antinociception induced by β-lactotensin, a neurotensin agonist peptide derived from β-lactoglobulin, is mediated by NT2 and D1 receptors. Life Sci., in press.
  • 14) Martin, S., Botto, J. M., Vincent, J. P., and Mazella, J., Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. Mol. Pharmacol., 55, 210-215 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.